DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma

Phase 2

Conditions: Primary Central Nervous System Lymphoma

Interventions: Drug: orelabrutinib
Drug: Sintilimab
Drug: Tislelizumab

First Posted Date: 2021-05-24

Last Posted Date: 2021-05-24

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 32

Registration Number: NCT04899427

Locations: 🇨🇳
Wei Zhang, Beijing, Beijing, China

Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL

Phase 2

Conditions: Primary Vitreoretinal Lymphoma

Interventions: Drug: Methotrexate
Drug: Rituximab
Drug: Zanubrutinib

First Posted Date: 2021-05-24

Last Posted Date: 2021-05-24

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 42

Registration Number: NCT04899453

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Phase 2

Conditions: Avatrombopag
Thrombocytopenia

Interventions: Drug: Avatrombopag

First Posted Date: 2021-05-21

Last Posted Date: 2021-05-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT04896528

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Phase 2

Conditions: Lupus Nephritis
Immunosuppression
Effect of Drug

Interventions: Drug: Sirolimus

First Posted Date: 2021-05-19

Last Posted Date: 2021-05-19

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 20

Registration Number: NCT04892212

Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population

Completed

Conditions: Vagina Disease
Vaginal Community State Type

First Posted Date: 2021-05-14

Last Posted Date: 2024-04-11

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 1000

Registration Number: NCT04887636

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer

Not Applicable

Conditions: Differentiated Thyroid Cancer

Interventions: Diagnostic Test: 124I PET/CT

First Posted Date: 2021-05-11

Last Posted Date: 2021-05-11

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 10

Registration Number: NCT04880798

Locations: 🇨🇳
Beijing Cancer Hospital, Beijing, China
🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Phase 2

Completed

Conditions: Pheochromocytoma, Metastatic
Malignant Adrenal Gland Pheochromocytoma
Malignant Paraganglioma
Paraganglioma, Malignant
Paraganglioma, Extra-Adrenal

Interventions: Drug: anlotinib hydrochloride

First Posted Date: 2021-04-27

Last Posted Date: 2024-06-12

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 27

Registration Number: NCT04860700

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Gallium-68 Labeled Pentixafor PET/CT in Adrenal Masses

Phase 2

Conditions: Adrenal Mass

Interventions: Diagnostic Test: Gallium-68 Pentixafor PET/CT

First Posted Date: 2021-04-26

Last Posted Date: 2021-04-26

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 150

Registration Number: NCT04859959

Locations: 🇨🇳
Peking Union Medical College Hospital, Peking, China

To Differentiate Focal Autoimmune Pancreatitis from Pancreatic Cancer by Endoscopic Ultrasound

Recruiting

Conditions: Autoimmune Pancreatitis
Pancreatic Cancer

Interventions: Other: EUS for derivation sample
Other: Diagnostic imaging modalities for validation sample

First Posted Date: 2021-04-08

Last Posted Date: 2024-10-30

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 600

Registration Number: NCT04834505

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System

Conditions: Ultrasonography
Breast Tumor

First Posted Date: 2021-04-01

Last Posted Date: 2021-04-01

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 152

Registration Number: NCT04825444

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy